Bulk Infliximab from Mexico
Bulk Infliximab is a chimeric monoclonal antibody against tumor necrosis factor (TNF), used in the treatment of autoimmune diseases. It is an unmixed immunological product, not put up in measured doses or retail packaging, and is intended for further manufacturing. It qualifies under tariff item 3002.13.00 as an antibody directly involved in the regulation of immunological processes.
Duty Rate — Mexico → Canada
0%
Import Tips
• Provide evidence that the product is unmixed and not in retail form to CBSA
• Ensure the product is classified correctly by referencing the chapter note on immunological products
• Check if a Drug Establishment Licence is required for importing active pharmaceutical ingredients